Skip to main content

Table 1 General characteristic of the included studies. NA not available, RCT randomized controlled trial, DHS dynamic hip screw, CHS compression hip screw, PCCP percutaneous compression plate, Medoff sliding plate, LISS less invasive stabilization system, PFN proximal femoral nail, PFNA proximal femoral nail anti-rotating

From: Optimal surgical methods to treat intertrochanteric fracture: a Bayesian network meta-analysis based on 36 randomized controlled trials

Authors

Intervention

Comparator

Follow-up (months)

Type of fracture

Age (mean, year)

Study

BMI (kg/m2)

Outcomes

Leung et al. [20]

Gamma nail

CHS

7.2

31-A1–A3

83.35

RCT

NA

1,2,3,4

Goldhagen et al. [21]

Gamma nail

DHS

6

31-A1–A3

80.6

RCT

NA

1,2,3,4

Butt et al. [22]

Gamma nail

DHS

6

31-A2–A3

79

RCT

NA

1,2,3,4

O’Brien et al. [23]

Gamma nail

DHS

13

31-A1–A2

81.2

RCT

NA

1,2,3,4

Hoffman and Lynskey [24]

Gamma nail

DHS

12

31-A1–A3

62.25

RCT

NA

1, 3,4

Kukla et al. [25]

Gamma nail

DHS

6

31-A1–A3

81.9

RCT

NA

1,2,3,4

Ahrengart et al. [26]

Gamma nail

CHS

6

31-A1–A3

79.6

RCT

NA

1,2,3,4

Kosygan et al. [27]

PCCP

CHS

19

31-A1–A3

72.95

RCT

NA

1,2,3,4

Utrilla et al. [28]

Gamma nail

CHS

12

31-A1–A3

80.2

RCT

NA

1,2,3,4

Ekström et al. [29]

Gamma nail

Medoff sliding plate

6

31-A2

83.2

RCT

NA

1,2,3,4

Peyser et al. [30]

PCCP

CHS

12

31-A2

80.85

RCT

NA

1,2,3,4

Romero et al. [31]

DHS

PCCP

12

31-A1–A3

82.9

RCT

NA

1,2,3,4

Zou et al. [32]

DHS

PFNA

12

31-A1–A3

82.5

RCT

NA

1,2,4

Xu et al. [33]

DHS

PFNA

12

31-A1–A3

62.25

RCT

NA

1,2,3,4

Yaozeng et al. [34]

Gamma nail

PFNA

6

31-A1–A3

NS

RCT

NA

1,3,4

Yang et al. [35]

PCCP

DHS

15

31-A1–A3

71.2

RCT

NA

1,2,3,4

Guo et al. [36]

PCCP

PFNA

12

31-A1–A2

83.55

RCT

NA

1,2,3,4

Sharma et al. [37]

PFNA

DHS

6

31-A1–A3

81

RCT

NA

1,2,3,4

Singh et al. [38]

PFNA

DHS

5

31-A1–A3

83.3

RCT

NA

1,2,3,4

Adeel et al. [39]

PFNA

DHS

12

31-A1–A3

82.5

RCT

NA

1,2,3,4

Brandt et al. [40]

PCCP

DHS

3

31-A1–A3

71.4

RCT

NA

1,2,3,4

Bridle et al. [41]

Gamma nail

DHS

6

31-A1–A3

NS

RCT

NA

1,2,3,4

Janzing et al. [42]

PCCP

DHS

12

31-A1–A3

76.2

RCT

NA

1,2,3,4

Kosygan et al. [27]

PCCP

DHS

19

31-A1–A3

83

RCT

23.2

1,2,3,4

Madsen et al. [43]

Gamma nail

DHS

6

31-A1–A3

82.9

RCT

NA

1,2,3,4

McCormack et al. [44]

DHS

Medoff sliding plate

6

31-A1–A3

81

RCT

NA

1,2,3

Miedel et al. [45]

Gamma nail

Medoff sliding plate

12

31-A1–A3

68.9

RCT

NA

1,2,3,4

O’Brien et al. [23]

Gamma nail

DHS

13

31-A1–A3

70.4

RCT

NA

1,2,3,4

Pajarinen et al. [46]

DHS

Gamma nail

4

31-A1–A2

80.2

RCT

21.8

1,2,3,4

Park et al. [47]

Gamma nail

CHS

12

31-A1–A3

76.2

RCT

NA

1,2,3,4

Parker et al. [48]

Gamma nail

CHS

12

31-A1–A2

72.9

RCT

NA

1,2,3,4

Radford et al. [49]

DHS

Gamma nail

12

31-A1–A3

NS

RCT

NA

1,2,3,4

Schipper et al. [50]

Gamma nail

PFN

12

31-A1–A3

NS

RCT

NA

1,3,4

Utrilla et al. [28]

Gamma nail

CHS

12

31-A2

NS

RCT

NA

1,2,3,4

Vaquero et al. [51]

PFNA

Gamma nail

12

31-A1–A3

72.85

RCT

NA

1,2,3,4

Zhou et al. [52]

LISS

PFNA

12

31-A1–A3

75.7

RCT

NA

1,2,3,4